Genital Herpes Suppressive Medications
Genital Herpes Suppressive Medications
Overview
Genital herpes is caused primarily by herpes simplex virus type 2 (HSV-2) and sometimes type 1 (HSV-1). After initial infection, the virus can reactivate intermittently, causing symptomatic outbreaks and viral shedding that can transmit to partners.
Suppressive antiviral therapy reduces the frequency and severity of recurrences, decreases asymptomatic viral shedding, and lowers the risk of sexual transmission.
Common suppressive medications
Acyclovir (Zovirax)
Typical suppressive dosing for adults: 400 mg orally twice daily.
Often used when cost or tolerance considerations matter; requires more frequent dosing than newer agents.
Valacyclovir (Valtrex)
Typical suppressive dosing for adults: 500 mg once daily for those with less frequent recurrences; 1,000 mg once daily for persons with more frequent recurrences or for higher-risk transmission reduction.
Prodrug of acyclovir with better oral bioavailability; convenient once-daily dosing for many patients.
Famciclovir (Famvir)
Typical suppressive dosing for adults: 250 mg twice daily.
Another alternative with good efficacy and twice-daily dosing.
Who should consider suppressive therapy
People with frequent symptomatic recurrences (commonly defined as six or more outbreaks per year, though lower thresholds may apply depending on impact on quality of life).
Individuals whose outbreaks are severe or prolonged.
Persons in serodiscordant partnerships (one partner HSV-positive, the other HSV-negative) who want to reduce transmission risk.
Pregnant people under guidance of a clinician (management in pregnancy requires specific evaluation).
Those who experience significant psychosocial distress or reduced sexual/relationship functioning due to herpes.
Benefits of suppressive therapy
Reduces the number of symptomatic recurrences by about 70–80% for many patients.
Shortens duration and severity of breakthrough episodes.
Decreases asymptomatic viral shedding substantially; valacyclovir daily has been shown to reduce transmission risk to susceptible partners.
Improves quality of life and sexual confidence for many patients.
Limitations and considerations
Suppressive therapy is not a cure. Antivirals suppress replication but do not eradicate latent virus.
Medication must generally be taken daily for ongoing suppression; benefits decline after stopping therapy.
Breakthrough recurrences can still occur while on suppressive therapy.
Side effects are usually mild (headache, nausea, rarely renal effects). Dose adjustment is necessary for renal impairment; older adults and those with compromised kidney function require careful dosing and monitoring.
Drug interactions are limited but should be reviewed with all current medications.
Long-term safety: Generally well tolerated long term for most people, but periodic reassessment by a clinician is advised.
Practical points for patients
Discuss goals with your clinician: frequency reduction, transmission risk reduction, or both.
Obtain baseline kidney function tests if you have reduced renal function risk factors (older age, diabetes, hypertension, dehydration, or concomitant nephrotoxic drugs).
Use condoms and avoid sexual contact during symptomatic outbreaks; suppressive therapy reduces but does not eliminate transmission risk.
Consider partner testing and open communication in relationships.
If you’re pregnant or trying to conceive, consult obstetric care immediately; specific guidelines apply for management in pregnancy and around delivery.
For episodic (as-needed) therapy at the first sign of an outbreak, higher short-course doses are used and differ from suppressive dosing—discuss with your clinician to choose the right approach.
When to seek medical advice
New or uncertain symptoms (first episode should be evaluated to confirm diagnosis and consider appropriate management).
Frequent or worsening recurrences despite therapy.
Signs of adverse effects (especially decreased urination, confusion, severe rash, or allergic reaction).
Pregnancy, planned conception, or fertility concerns.
Summary
Suppressive antiviral therapy (acyclovir, valacyclovir, famciclovir) is an effective strategy to reduce genital herpes recurrences, diminish asymptomatic shedding, and lower sexual transmission risk. It is safe for most people when dosed appropriately, but it is not a cure.
Work with a healthcare provider to determine whether suppressive therapy aligns with your clinical needs and life goals, to monitor kidney function when indicated, and to integrate medications with safer-sex practices and partner communication.
